Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America
{{output}}
Objectives: Toripalimab combined with chemotherapy is a clinically valuable and important regimen in the treatment of extensive-stage small-cell lung cancer (ES-SCLC). However, there are no studies on the cost-effectiveness of th... ...
